Clinical research

Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation

EuroIntervention 2013;8:1157-1165 published online ahead of print December 2012. DOI: 10.4244/EIJV8I10A179

Ricardo Petraco
Ricardo Petraco1*, MD; Jin Joo Park3, MD; Sayan Sen1, MBBS; Sukhjinder S. Nijjer1, MBChB; Iqbal S. Malik1, MBBS, PhD; Mauro Echavarría-Pinto², MD; Kaleab N. Asrress6, MA, BM, BCh; Chang-Wook Nam4, MD, PhD; Enrico Macías², MD; Rodney A. Foale1, MD; Amarjit Sethi1, MBBS, PhD; Ghada W. Mikhail1, MBBS, MD; Raffi Kaprielian1, MBBS, MD; Christopher S. Baker1, MBBS, PhD; David Lefroy1, MB, BChir; Michael Bellamy1, MBBS, MD; Mahmud Al-Bustami1, MD; Masood A. Khan1, MB, BChir, MA; Nieves Gonzalo², MD, PhD; Alun D. Hughes
1. International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom; 2. Cardiovascular Institute, Hospital Clínico San Carlos, Madr

Aims: Adoption of fractional flow reserve (FFR) remains low (6-8%), partly because of the time, cost and potential inconvenience associated with

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

instantaneous wave-free ratiofractional flow reservephysiology-guided pciadenosine
Read next article
Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve

Latest news